OTHER INCOME AND EXPENSES (Tables)

3 Months Ended

Mar. 31, 2022

Other Income and Expenses [Abstract]

Schedule of Other Income (Expense)

Other income (expense) net consisted of the following for the years ended December 31, 2021 and 2020:

	December 31, 2021		December 31, 2020
Impairment of LPB related assets	(1,076,258)		—
Equity loss in affiliates	(2,049,070)		(2,131)
Tonogold reimbursement of Pelen LLC acquisition costs	—		234,944
Change in fair value of Tonogold preferred shares	—		(2,544,000)
Change in fair value Tonogold note receivable	(418,500)		(642,997)
Tonogold note receivable amendment fee income	362,500		—
Writedown of uncollectible receivable	(300,000)		—
Recognition of grant from CARES Act PPP loan	—		261,170
LINICO dividend income	426,763		—
Other	75,202		425,185
Total other income (expense)	$	(2,979,363)	$	(2,267,829)

Other income (expense) net consisted of the following for the three months ended March 31, 2022 and March 31, 2021:

	March 31, 2022		March 31, 2021
Change in fair value Tonogold note receivable	(605,000)		745,500
Tonogold amendment fee and charges	14,652		262,500
LPB settlement and related expenses	(250,000)		—
Equity loss in affiliates	(266,903)		(31,454)
All other	(23,556)		22,945
Total other income (expense)	$	(1,130,807)	$	999,491